Mounica Vallurupalli, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Copper | 2 | 2019 | 366 | 1.160 |
Why?
|
Celiac Disease | 2 | 2019 | 785 | 0.800 |
Why?
|
Anemia, Macrocytic | 1 | 2019 | 55 | 0.700 |
Why?
|
Duodenum | 2 | 2019 | 483 | 0.700 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 256 | 0.550 |
Why?
|
Zinc | 1 | 2019 | 683 | 0.520 |
Why?
|
Interleukin-1beta | 1 | 2020 | 972 | 0.480 |
Why?
|
Adaptation, Psychological | 2 | 2013 | 2575 | 0.400 |
Why?
|
Grief | 1 | 2013 | 247 | 0.390 |
Why?
|
Anemia | 1 | 2020 | 1499 | 0.370 |
Why?
|
Antibodies, Neutralizing | 1 | 2019 | 1970 | 0.360 |
Why?
|
Bone Marrow | 1 | 2019 | 2941 | 0.340 |
Why?
|
Death | 1 | 2013 | 675 | 0.330 |
Why?
|
Religion | 1 | 2011 | 356 | 0.320 |
Why?
|
Spirituality | 1 | 2011 | 405 | 0.300 |
Why?
|
Hemoglobins | 2 | 2020 | 1532 | 0.230 |
Why?
|
Cystic Fibrosis | 1 | 2012 | 1178 | 0.220 |
Why?
|
Antibodies, Monoclonal | 1 | 2019 | 9274 | 0.210 |
Why?
|
Fatigue | 2 | 2019 | 1526 | 0.210 |
Why?
|
Dyspnea | 2 | 2019 | 1298 | 0.200 |
Why?
|
Myelodysplastic Syndromes | 2 | 2021 | 1351 | 0.180 |
Why?
|
Palliative Care | 2 | 2012 | 3478 | 0.180 |
Why?
|
Anemia, Hypochromic | 1 | 2019 | 66 | 0.180 |
Why?
|
Bone Marrow Examination | 1 | 2019 | 157 | 0.170 |
Why?
|
Deficiency Diseases | 1 | 2019 | 72 | 0.170 |
Why?
|
Physician-Patient Relations | 1 | 2012 | 3215 | 0.160 |
Why?
|
Internship and Residency | 2 | 2021 | 5774 | 0.160 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2018 | 188 | 0.160 |
Why?
|
Diet, Gluten-Free | 1 | 2019 | 271 | 0.150 |
Why?
|
Endoscopy, Digestive System | 1 | 2019 | 345 | 0.140 |
Why?
|
Stress, Psychological | 1 | 2012 | 4229 | 0.140 |
Why?
|
Nausea | 1 | 2019 | 665 | 0.140 |
Why?
|
Hemangiosarcoma | 1 | 2018 | 236 | 0.140 |
Why?
|
Antifibrinolytic Agents | 1 | 2018 | 254 | 0.140 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2021 | 730 | 0.130 |
Why?
|
Physicians | 1 | 2013 | 4554 | 0.130 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12958 | 0.120 |
Why?
|
Cyclin D1 | 1 | 2015 | 462 | 0.110 |
Why?
|
Guilt | 1 | 2013 | 95 | 0.110 |
Why?
|
Neoplasms | 3 | 2023 | 21596 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2015 | 535 | 0.100 |
Why?
|
DNA Repair | 1 | 2021 | 2042 | 0.100 |
Why?
|
Quality of Life | 1 | 2011 | 12730 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2020 | 3199 | 0.090 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 944 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3444 | 0.090 |
Why?
|
Teaching Rounds | 1 | 2013 | 253 | 0.090 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3766 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2023 | 3585 | 0.080 |
Why?
|
Recurrence | 1 | 2019 | 8333 | 0.080 |
Why?
|
Drug Discovery | 1 | 2015 | 1057 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3711 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4147 | 0.070 |
Why?
|
Medical Oncology | 3 | 2023 | 2235 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12017 | 0.070 |
Why?
|
Middle Aged | 6 | 2020 | 213127 | 0.060 |
Why?
|
Female | 9 | 2021 | 379592 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2021 | 3497 | 0.060 |
Why?
|
Humans | 14 | 2023 | 742088 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1875 | 0.060 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 1028 | 0.060 |
Why?
|
Anticoagulants | 1 | 2018 | 4595 | 0.060 |
Why?
|
Lung Transplantation | 1 | 2012 | 1155 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2522 | 0.060 |
Why?
|
Mice, SCID | 2 | 2021 | 2715 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4249 | 0.050 |
Why?
|
Hearing Loss | 1 | 2009 | 765 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 20928 | 0.050 |
Why?
|
U937 Cells | 1 | 2021 | 268 | 0.050 |
Why?
|
Autoantibodies | 1 | 2009 | 2036 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3557 | 0.050 |
Why?
|
Students, Medical | 1 | 2013 | 1858 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3839 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 632 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5522 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11690 | 0.040 |
Why?
|
Accreditation | 1 | 2021 | 449 | 0.040 |
Why?
|
Phthalazines | 1 | 2021 | 361 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3769 | 0.040 |
Why?
|
Decision Making | 1 | 2012 | 3869 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7770 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2021 | 1866 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2130 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2723 | 0.040 |
Why?
|
Male | 6 | 2021 | 349538 | 0.040 |
Why?
|
Thrombopoietin | 1 | 2018 | 223 | 0.040 |
Why?
|
Mutation | 1 | 2021 | 29717 | 0.030 |
Why?
|
Receptors, Fc | 1 | 2018 | 540 | 0.030 |
Why?
|
RNA-Binding Protein EWS | 1 | 2015 | 216 | 0.030 |
Why?
|
Aged | 2 | 2020 | 162944 | 0.030 |
Why?
|
Lung | 1 | 2012 | 9826 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2015 | 322 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 552 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13655 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16665 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 1130 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2423 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 24913 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2015 | 1213 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2018 | 3770 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1905 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2917 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2021 | 2283 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9735 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3589 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5892 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2890 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5851 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1683 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5872 | 0.020 |
Why?
|
Ear, Inner | 1 | 2009 | 420 | 0.020 |
Why?
|
Adolescent | 1 | 2012 | 85649 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 21821 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18006 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2015 | 8425 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11472 | 0.010 |
Why?
|
Animals | 2 | 2021 | 168561 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81045 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40054 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23387 | 0.010 |
Why?
|
Adult | 1 | 2009 | 213712 | 0.000 |
Why?
|